Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients

20164,967 citationsJournal Articlebronze Open Access

Authors

Martin B. Leon · Columbia University Irving Medical Center

Craig R. Smith · Columbia University Irving Medical Center

Michael J. Mack · Baylor Scott & White Health

Raj Makkar · Cedars-Sinai Medical Center

Lars G. Svensson · Cleveland Clinic

Susheel Kodali · Columbia University Irving Medical Center

Vinod H. Thourani

Abstract

In intermediate-risk patients, TAVR was similar to surgical aortic-valve replacement with respect to the primary end point of death or disabling stroke. (Funded by Edwards Lifesciences; PARTNER 2 ClinicalTrials.gov number, NCT01314313.).

Topics & Keywords

Cardiac Valve Diseases and Treatments Cardiovascular Function and Risk Factors Infective Endocarditis Diagnosis and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: New England Journal of Medicine

Volume 374, Issue 17, pp. 1609-1620

DOI: 10.1056/nejmoa1514616

Field-Weighted Citation Impact: 443.72